Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes

NCT00592527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin detemir

Sponsor

Novo Nordisk A/S